Tim Watkins
Cmo & Head Of Development at Contineum Therapeutics, Inc. (CTNM)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $323K
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jul 1SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 10,8338,961 held (−55%) | $16.02 | $174K | -16.5% |
| Mar 2SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 3,611 | $15.02 | $54K | -10.9% |
| Jan 30SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 2,800811 held (−78%) | $14.09 | $39K | -5.0% |
| Jan 30SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 811 | $14.48 | $12K | -7.6% |
| Dec 30SEC | CTNMContineum Therapeutics, Inc. | Sell Plan | 3,611 | $12.06 | $44K | +10.9% |
- Sell
Cmo & Head Of Development Tim Watkins sold $174K of CTNM at $16.02 — cuts the stake by 55%; pre-scheduled 10b5-1 plan sale.
- Sell
Cmo & Head Of Development Tim Watkins sold $54K of CTNM at $15.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Cmo & Head Of Development Tim Watkins sold $39K of CTNM at $14.09 — cuts the stake by 78%; pre-scheduled 10b5-1 plan sale.
- Sell
Cmo & Head Of Development Tim Watkins sold $12K of CTNM at $14.48 — pre-scheduled 10b5-1 plan sale.
- Sell
Cmo & Head Of Development Tim Watkins sold $44K of CTNM at $12.06 — pre-scheduled 10b5-1 plan sale.